选择性COX-2抑制剂Celecoxib对胃癌细胞增殖影响的探讨

孙现军, 侯文红, 马恒, 王兴武, 王永胜, 徐忠法, 姜希宏

孙现军, 侯文红, 马恒, 王兴武, 王永胜, 徐忠法, 姜希宏. 选择性COX-2抑制剂Celecoxib对胃癌细胞增殖影响的探讨[J]. 中国肿瘤临床, 2004, 31(20): 1171-1173,1174.
引用本文: 孙现军, 侯文红, 马恒, 王兴武, 王永胜, 徐忠法, 姜希宏. 选择性COX-2抑制剂Celecoxib对胃癌细胞增殖影响的探讨[J]. 中国肿瘤临床, 2004, 31(20): 1171-1173,1174.
Sun Xianjun, Hou Wenhong, Ma Heng, Wang Xingwu, Wang Yongsheng, Xu Zhongfa, Jiang Xihong. Effect of Selective Cyclooxygenase-2 Inhibitor Celecoxib on Proliferation of Gastric Cancer Cell[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2004, 31(20): 1171-1173,1174.
Citation: Sun Xianjun, Hou Wenhong, Ma Heng, Wang Xingwu, Wang Yongsheng, Xu Zhongfa, Jiang Xihong. Effect of Selective Cyclooxygenase-2 Inhibitor Celecoxib on Proliferation of Gastric Cancer Cell[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2004, 31(20): 1171-1173,1174.

选择性COX-2抑制剂Celecoxib对胃癌细胞增殖影响的探讨

详细信息
  • 中图分类号: R735.2

Effect of Selective Cyclooxygenase-2 Inhibitor Celecoxib on Proliferation of Gastric Cancer Cell

  • 摘要: 目的 :探讨选择性COX-2抑制剂Celecoxib对胃癌SGC-7901细胞增殖和凋亡的影响。 方法 :应用MTT法和FCM检测Celecoxib对胃癌SGC-7901细胞增殖、细胞凋亡、细胞周期和COX-2蛋白和bcl-2蛋白表达的影响。 结果 :Celecoxib呈时间、剂量依赖性抑制胃癌SGC-7901细胞生长,72h细胞最高存活率为48.7%,最低为20.5%;COX-2蛋白含量由26.73±0.06降至5.79±1.44,bcl-2蛋白含量由2.76±0.14降至0.78±0.05,COX-2蛋白和bcl-2蛋白表达的降低呈浓度依赖性;随着药物浓度的增高,细胞凋亡率由3.0%增加到33.0%;G0/G1期细胞比例增加到(87.29±1.34)%,S期和G2/M期细胞比例分别降低到(8.91±0.78)%、(3.80±0.55)%。 结论 :Celecoxib能够诱导胃癌SGC-7901细胞的凋亡,影响细胞周期的分布,从而有效地抑制胃癌SGC-7901细胞的增殖;Celecoxib诱导胃癌SGC-7901细胞的凋亡可能主要通过抑制COX-2的生物活性来实现,并与bcl-2蛋白表达的下调有关。
    Abstract: Objective :To study the the effect of selective COX-2 inhibitor Celecoxib on proliferation and apoptosis of gastric cancer cell. Methods :Investigate the effect of Celecoxib on proliferation of gastric cancer cell line SGC-7901 by MTT assay.Detect the change of apoptosis,cell cycle and the expression of COX-2,bcl-2 protein using flow cytometry analysis. Results :Celecoxib could inhibit the proliferation of SGC-7901 cell and showed a time-and dose-dependent manner.The highest survival rate of SGC-7901 cell is 48.7% and the lowest is 20.5% after 72 hour of Celecoxib action.The content of COX-2 and bcl-2 protein was decreased from 26.73±0.06 to 5.79±1.44,from 2.76±0.14 to 0.78±0.05 respectively.The decrease of them showed a dose-dependent manner.The apoptosis rate of the cell increased from 3% to 33% with the raise of Celecoxib concentration.The percentage of cell in G0/G1 phase increased to 87.29±1.34% and the percentage of cell in S and G2/M phase reduced to 8.91±0.78%, 3.80±0.55%,respectively. Conclusions :Celecoxib could inhibit the proliferation of SGC-7901 cell effectively through inducing apoptosis and influencing the distribution of cell cycle of SGC -7901 cell.The mechanism of Celecoxib induced apoptosis of SGC-7901 cell mainly through inhibit the biological activity of COX-2 and may associated with the down-regulation of bcl-2 protein.
  • [1] Son HJ,Kim YH,Park D,et al.Interaction between cyclooxyge-nase? and inducible nitric oxide synthase in gastric cancer [J],J Clin Gastroenterol,2001,33(5):383-388
    [2] Fosslien E.Biochemistry of cyclooxygenase (COX)-2 inhibitors and molecular pathology of COX-2 in neoplasia [J],Crit Review Clin Lab Sci,2000,37(5):431-502
    [3] Penning TD,Talley JJ,Bertenshaw SR,et al.Synthesis and bio-logical evaluation of the 1,5 -iarylpyrazole class of cyclooxyge-nase-2 inhibitors: identification of 4-[5-(4-ethylphenyl)-3-(trifluoromethyl)-1H-pyrazol-l-y1]benzenesulfonamide (SC-58635,celecoxib)[J].J Med Chem,1997,40(9):1347-1365
    [4] Leahy KM,Ornberg RL,Wang Y,et al.Cyclooxygenase-2 inhi-bition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in Vivo [J].Caner Res,2002,62(3):625-631
    [5] Nzeako UC,Guicciardi ME,Yoon JH,et al.COX-2 inhibits fas?ediated apoptosis in cholangiocarcinoma cells [J].Hepatolo-gy,2002,35(3):552-559
    [6] Willams CS,Waston AJM,Sheng H,et al.Celecoxib prevents tumor growth in Vivo without toxity to normal gut:lack of corre-lation between in Vitro and in Vivo models[J].Cancer Res,2000,60(21):6045-6051
    [7] Tang X,Sun +J,Half E,et al.Cyclooxygenase-2 overexpression inhibits death receptor 5 expression and confers resistance to tu-mor necrosis factor elated apoptosis nducing ligand nduced apoptosis in human colon cancer cells [J].Cancer Res,2002,62 (17):4903-4908
    [8] Sawaoka H,Kawano S,Tsuji S,et al.Cyclooxygenase-2 in-hibitors suppress the growth of gastric cancer xenografts via in-duction of apoptosis in nude mice [J].Am J Physiol Gastrointest Liver Physiol,1998,274:G1O61-G1O67
    [9] Waskewich C,Blumenthal RD,Li H,et al.Celecoxib exhibits the greatest potency amongst cyclooxygenase (COX) inhibitors for growth inhibition of COX-2 negative hematopoietic and epithe-lial cell lines.Cancer Res,2OO2,62(7):2O29-2O33
    [10] Kundu N,Smith MJ,Samsel L,et al.Cyclooxygenase inhibitors block cell growth,increase ceramide and inhibit cell cycle [J].Breast Cancer Res Treat,2OO2,76(1):57-64.
计量
  • 文章访问数:  5
  • HTML全文浏览量:  0
  • PDF下载量:  1
  • 被引次数: 0
出版历程
  • 收稿日期:  2004-01-31
  • 修回日期:  2004-06-24
  • 发布日期:  2004-10-30

目录

    /

    返回文章
    返回